NCT03337932View on ClinicalTrials.gov

Duration of Doxycycline Treatment in MEM Patients

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2027

Conditions
Erythema Chronicum Migrans
Interventions
DRUG

Doxycycline 100 milligram Oral Tablet bid, 7 days

Patients will receive doxycycline for 7 days.

DRUG

Doxycycline 100 milligram Oral Tablet bid, 14 days

Patients will receive doxycycline for 14 days.

DRUG

Controls without a history of lyme disease.

No intervention.

Trial Locations (1)

Unknown

RECRUITING

University Medical center Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER